Prostate cancer: Unravelling AR splice variant signalling in CPRC

Nature Reviews Urology

Volumn 9, Issue 8, 2012, Pages 410-

  Fenner, Annette ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

4 [3 [4 CYANO 3 (TRIFLUOROMETHYL)PHENYL] 5,5 DIMETHYL 4 OXO 2 THIOXO 1 IMIDAZOLIDINYL] 2 FLUORO N METHYLBENZAMIDE; ABIRATERONE; ANDROGEN RECEPTOR; MESSENGER RNA; ISOPROTEIN;

ADVANCED CANCER; CANCER GROWTH; CASTRATION RESISTANT PROSTATE CANCER; HUMAN; LIGAND BINDING; MOLECULARLY TARGETED THERAPY; NOTE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; TRANSURETHRAL RESECTION; TUMOR GROWTH; ANIMAL; GENE EXPRESSION REGULATION; MALE; METABOLISM; NEOPLASM; PROSTATIC NEOPLASMS;

ANIMALS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; MALE; NEOPLASMS, HORMONE-DEPENDENT; PROSTATIC NEOPLASMS; PROTEIN ISOFORMS; RECEPTORS, ANDROGEN;

EID: 84864878875     PISSN: 17594812     EISSN: 17594820     Source Type: Journal    
DOI: 10.1038/nrurol.2012.139     Document Type: Note

References (1)

1. Hu, R. et al. Distinct transcriptional programs mediated by the ligand-dependent full-length androgen receptor and its splice variants in castration-resistant prostate cancer. Cancer Res. doi:10.1158/0008-5472CAN-11- 3892